Health-care companies rose amid anticipation of further deal activity.
The Federal Trade Commission is preparing to sue the largest three pharmacy-benefit managers -- UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts -- over their tactics for negotiating prices for drugs including insulin, after a two-year investigation into whether the companies steer patients away from less-expensive medicines.
Shares of Becton Dickinson rose after the Food and Drug Administration addressed supply issues surrounding blood-culture vials.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
07-10-24 1828ET